CSL NEW ZEALAND ALBUMEX 20 human albumin 200g/L injection solution vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Albumin, Quantity: 200 g/L

Commercializzato da:

CSL Behring Australia Pty Ltd

INN (Nome Internazionale):

Albumin

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: octanoate; sodium

Via di somministrazione:

Intravenous

Confezione:

100 mL

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

STORAGE CONDITIONS: PROTECT FROM LIGHT 1. Hypoproteinaemia in acutely ill patients: (a) to increase oncotic pressure (b) as an adjunct to diuretic therapy (c) as a nutrient in paediatrics. 2. Resuscitation. In shock due to acute blood or plasma loss together with crystalloid solutions. 3. Burns. To maintain colloid osmotic pressure. 4. Adult Respiratory Distress Syndrome - used with diuretics. 5. Haemodialysis - Assists in the rapid removal of excess extravascular fluid and maintain perfusion pressure. 6. Therapeutic Plasma Exchange -used when a patient's serum albumin level is not maintained.

Dettagli prodotto:

Visual Identification: Neutral type 1 glass vial, closed with a butyl rubber stopper and sealed with an aluminium cap; clear pale yellow-green solution; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

1995-12-13